> Dear Allstaters,
>
> please find attached the latest contract vacancy for you to review;
>
> TITLE: SAS Programmer - Phase I-II Clinical Trials
>
> DESCRIPTION: Essential; 3 years minimum SAS programming within the
> pharmaceutical / CRO industries, SAS/base, SAS/macro & a good
> understanding of data management processes. Working for this major
> pharmaceutical client you will be responsible for the SAS programming of
> derived datasets, listings & figures. Your duties include; reviewing
> protocols / CRFs / reporting & analysis plans, reporting of datasets,
> support CDM activities, develop / test SAS programs, produce tables /
> summaries / listings & work closely with CROs in reporting activities.
>
> START DATE: ASAP, but they will wait for notice period.
> LOCATION: UK based role, in the South East
> RATE: Dependant on experience
> CONTRACT LENGTH: 12 months+
>
> If you are interested in this role please get in contact ASAP for more
> details.
>
> Regards
>
James Carrera
European Contracts Manager
Pharmaceutical, Healthcare & CRO division
1st IT People
Tel: +44 (0) 207 255 6665
Mobile: +44 7717 578 246
Fax: +44 (0) 207 255 6656
mailto:[log in to unmask]
<mailto:[log in to unmask]>
www.1st-itpeople.com <http://www.1st-itpeople.com>
PLEASE NOTE: As of 31st May 2005 our office address will change to; 1st IT
People, 3rd Floor, Woolverstone House, 61-62 Berners Street, London. W1T
3NJ. As a result of this, we do have a new telephone number of 0207 255
6665. Please note our previous phone number will still work.
Offices in UK, Switzerland, The Netherlands & Hong Kong
This email is confidential and intended solely for the use of the individual
to whom it is addressed. Any views or opinions presented are solely those of
the author and do not represent those of the company from which the email
was sent. If you are not the intended recipient, be advised that you have
received this e-mail in error and that any use, dissemination forwarding,
printing or copying of this e-mail is strictly prohibited. While every
effort has been made to scan this e-mail, we can not accept any
responsibility for the loss of business or damage caused arising from this
email.
This email is confidential and intended solely for the use of the
individual to whom it is addressed. Any views or opinions presented are
solely those of the author and do not represent those of the company from
which the email was sent. If you are not the intended recipient, be advised
that you have received this e-mail in error and that any use, dissemination
forwarding, printing or copying of this e-mail is strictly prohibited.
While every effort has been made to scan this e-mail, we can not accept any
responsibility for loss of business or damage caused arising from this
e-mail.
|